Abstract:Background Lipids are ubiquitous metabolites with diverse functions. Excessive lipid accumulation can trigger lipid redistribution among metabolic organs such as adipose, liver and muscle, thus altering the lipid metabolism. It has been revealed that disturbed lipid metabolism would cause multiple disease complications and is highly correlated with human morbidity. Resveratrol (RSV), a phytoestrogen with antioxidant, can modulate insulin resistance and lipid profile. Recently, research on RSV supplementation to improve glucose and lipid metabolism has been controversial. A meta-analysis may provide a scientific reference for the relationship between lipid metabolism and RSV supplementation. Methods and Analysis We searched the PubMed, Cochrane Library, Web of Science, and Embase databases from inception to October 2021 using relevant keywords. A comprehensive search for randomized controlled trials (RCTs) was performed. For calculating pooled effects, continuous data were pooled by mean difference (MD) and 95% confidence interval (CI). Adopting the method of inverse-variance with a random-effect, all related statistical analyses were performed using the Rev Man V.5.3 and STATA V.15 software. Results A total of 25 articles were incorporated into the final meta-analysis after removal of duplicates by checking titles and abstracts and excluding non-relevant articles. The selected articles had a total of 1,171 participants, including 578 in the placebo group and 593 in the intervention group. According to the current meta-analysis, which demonstrated that there was a significant decrease in waist circumference (SMD = –0.36; 95% CI: –0.59, –0.14; P = 0.002; I 2 = 88%), hemoglobin A1c (–0.48; –0.69, –0.27; P ≤ 0.001; I 2 = 94%), total cholesterol (–0.15; –0.3, –0.01; P = 0.003; I 2 = 94%), low density lipoprotein cholesterol (–0.42; –0.57, –0.27; P ≤ 0.001; I 2 = 92%), high density lipoprotein cholesterol (0.16; –0.31, –0.02; P = 0.03; I 2 = 81%) following resveratrol administration. Conclusion These results suggest that RSV has a dramatic impact on regulating lipid and glucose metabolism, and the major clinical value of resveratrol intake is for obese and diabetic patients. We hope that this study could provide more options for clinicians using RSV. Furthermore, in the future, large-scale and well-designed trials will be warranted to confirm these results. Systematic Review Registration Website [ https://www.crd.york.ac.uk/prospero/#recordDetails ], identifier [CRD42021244904].

NMR-based metabonomic approach reveals changes in the urinary and fecal metabolome caused by resveratrol

Gut Microbiota Composition in Relation to the Metabolism of Oral Administrated Resveratrol

Effects of Resveratrol Supplementation on Risk Factors of Non-Communicable Diseases: A Meta-Analysis of Randomized Controlled Trials

The anti-inflammatory activity of resveratrol in acute kidney injury: a systematic review and meta‐analysis of animal studies

Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice.

Gut<i>Eggerthella lenta</i>promotes the efficacy of resveratrol through reductive metabolism

Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review

Resveratrol Ameliorates Metabolic Disorders and Muscle Wasting in Streptozotocin-Induced Diabetic Rats.

Gut promotes the efficacy of resveratrol through reductive metabolism

Alleviation Effects of Microbial Metabolites from Resveratrol on Non-Alcoholic Fatty Liver Disease

Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells

Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota

Chronic resveratrol administration reduces oxidative stress and brain cell loss and improves memory of recognition in old rats

Resveratrol-induced Gut Microbiota Reduces Obesity in High-Fat Diet-Fed Mice.

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota

Alteration of benzo(a)pyrene biotransformation by resveratrol in ApcMin/+ mouse model of colon carcinogenesis

The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression

Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota

Resveratrol Improves Growth Performance, Intestinal Morphology, and Microbiota Composition and Metabolism in Mice

Resveratrol Protects Against Renal Damage Via Attenuation of Inflammation and Oxidative Stress in High-Fat-Diet-Induced Obese Mice

Resveratrol Mitigates Uremic Toxin-Induced Intestinal Barrier Dysfunction in Chronic Kidney Disease by Promoting Mitophagy and Inhibiting Apoptosis Pathways